Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

ClinicalTrials.gov ID: NCT04786873

Public ClinicalTrials.gov record NCT04786873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Open Label Trial to Investigate the Efficacy and Safety of a Single Oral Dose of 1.0 mg/kg Macimorelin Acetate as Growth Hormone Stimulation Test (GHST) in Pediatric Patients With Suspected Growth Hormone Deficiency (GHD)

Study identification

NCT ID
NCT04786873
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AEterna Zentaris
Industry
Enrollment
101 participants

Conditions and interventions

Interventions

  • Macimorelin Drug
  • Arginine Diagnostic Test
  • Clonidine Diagnostic Test

Drug · Diagnostic Test

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2021
Primary completion
Jun 12, 2024
Completion
Jun 12, 2024
Last update posted
Aug 11, 2024

2021 – 2024

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Angel Wing Clinic For Children With Diabetes Tucson Arizona 85724
Pediatric Endocrine Associates, p.c. Greenwood Village Colorado 80111
John Hopkins All Children's Hospital St. Petersburg Florida 33701
Emory Healthcare-Children's Center Atlanta Georgia 30329
St. Luke's Children's Endocrinology Boise Idaho 83712
University of Minnesota, Masonic Children's Hospital Minneapolis Minnesota 55454
The Children's Mercy Hospital - Broadway Kansas City Missouri 64108
Icahn School of Medicine at Mount Sinai New York New York 10129
Children's Hospital at Montefiore The Bronx New York 10709
UNC Hospitals Chapel Hill North Carolina 27599
Alchemi Research Center Rosharon Texas 77583
Multicare Health System Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04786873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04786873 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →